Ynno Med
PrivateLast Round
Grant
Apr 1, 2025
Total Funding Raised
$1.13M
Company Overview
Ynno Med operates in Healthcare & Life Sciences and is based in Hong Kong. Its latest recorded funding round was a Corporate Funding round in October 2024.
Ynno Med is a biotech company that has developed a drug R&D platform dedicated to addressing antimicrobial resistance by discovering and developing new antimicrobial agents.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ynno Med Comparables
Compare Ynno Med with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evolvere BioSciences | 86% | |
| Phare Bio | 80% | |
| Genesis Molecular AI | 77% |
For institutional investors. Book with your work email.
Ynno Med Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 1, 2025 | ||||
| Corporate Funding | Oct 1, 2024 | ||||
| Grant | Apr 1, 2024 | ||||
| Grant | Apr 1, 2023 | ||||
| Grant | Apr 1, 2022 |
For institutional investors. Book with your work email.
Ynno Med Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hong Kong Science & Technology Parks Corporation (HKSTP) Incu-Bio Programme | Accelerator |
| Technology Start-up Support Scheme for Universities (TSSSU) | Grant |
| Hong Kong Science and Technology Parks Corporation | Accelerator |
| Innovation and Technology Commission | Grant |
| The Chinese University of Hong Kong | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2025
$115K grant from Innovation and Technology Commission.
- Oct 1, 2024
Raised $192K in corporate funding.
For institutional investors. Book with your work email.
Ynno Med Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ynno Med's valuation, stock price, and market status.
Is Ynno Med a public or private company?
Ynno Med is a private company.
What is the current stock price of Ynno Med?
Ynno Med is a private company, so its shares have no public market price. Caplight tracks Ynno Med's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ynno Med worth (valuation)?
Valuation information for Ynno Med is not publicly available.
Can I buy Ynno Med stock?
Ynno Med shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ynno Med's last funding round?
Ynno Med's most recent funding round was Grant on April 1, 2025.
Who are the main investors in Ynno Med?
Key investors in Ynno Med include Hong Kong Science and Technology Parks Corporation, Innovation and Technology Commission.
Will Ynno Med IPO soon?
No public IPO plans have been announced for Ynno Med.
How can I track Ynno Med secondary market activity?
Caplight tracks bids, offers, and trades in Ynno Med's shares on secondary markets.